Skip to content

Boston Scientific BSX Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

Abbott logo
AbbottABT
Edwards Lifesciences logo
Edwards LifesciencesEW
ResMed logo
ResMedRMD
Cardinal Health logo
Cardinal HealthCAH
ROP
Roper Technologies, Inc.ROP

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.4%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$66.81B-37.5%
P/E18.8×-34.0×
P/S3.2×-2.8×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's treasury stock, shares (in shares)?
Boston Scientific (BSX) reported treasury stock, shares (in shares) of 263.3M in Q1 2026.
How has Boston Scientific's treasury stock, shares (in shares) changed year-over-year?
Boston Scientific's treasury stock, shares (in shares) decreased by 0.0% year-over-year, from 263.3M to 263.3M.
What is the long-term trend for Boston Scientific's treasury stock, shares (in shares)?
Over 3 years (2022 to 2025), Boston Scientific's treasury stock, shares (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from 263.3M to 263.3M.